| |
Remark |
G Protein-coupled receptors
|
|
|
Cytokine receptors
|
|
|
Nuclear receptors
|
|
|
Ion channels
|
|
|
Transporters
|
|
|
Enzymes
|
|
|
Protein kinases
|
|
|
Cytokines
|
|
|
Others
|
Cell adhesion molecules (CAMs)
|
CD2 [HSA:914] [KO:K06449]
|
CD4 [HSA:920] [KO:K06454]
|
integrin alpha4/beta1 [HSA:3676 3688] [KO:K06483 K05719]
|
integrin alpha4/beta7 [HSA:3676 3695] [KO:K06483 K06590]
|
integrin alpha5/beta1 (VLA-5) [HSA:3678 3688] [KO:K06484 K05719]
|
Volociximab
|
D06319 Volociximab (USAN)
|
Monoclonal antibody
|
integrin alphav/beta3 (VNR) [HSA:3685 3690] [KO:K06487 K06493]
|
integrin alphav/beta5 [HSA:3685 3693] [KO:K06487 K06588]
|
integrin alphaE/beta7 [HSA:3682 3695] [KO:K06524 K06590]
|
LFA-1 (CD11A / CD18) [HSA:3683 3689]
|
CR3 (CD11B / CD18) [HSA:3684 3689]
|
glycoprotein alpha IIb/beta3 (GPIIb/IIIa) receptor [HSA:3674 3690] [KO:K06476 K06493]
|
Cellular antigens
|
Toll-like receptors
|
T-cell co-receptor
|
Glycan binding proteins
|
Heparin binding proteins
|
Lipid transfer proteins
|
Cytoskeleton proteins
|
SNARE proteins
|
Antibodies
|
Complement system
|
Inhibitors of apoptosis (IAP) protein family
|
Nucleic acid
|